These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9923056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM.
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [Abstract] [Full Text] [Related]

  • 5. The effect of levocabastine nasal spray in nasal provocation tests.
    Palma-Carlos AG, Palma-Carlos ML, Rombaut N.
    Int J Clin Pharmacol Res; 1988 Sep; 8(1):25-30. PubMed ID: 2896636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
    Palma-Carlos AG, Chieira C, Conde TA, Cordeiro JA.
    Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC, Martin BG, Dolen J, Travers S, Karcher K, Holton D.
    Am J Rhinol; 1999 Oct; 13(1):55-62. PubMed ID: 10088031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of terfenadine on nasal, eustachian tube, and pulmonary function after provocative intranasal histamine challenge.
    Skoner DP, Doyle WJ, Boehm S, Fireman P.
    Ann Allergy; 1991 Dec; 67(6):619-24. PubMed ID: 1750727
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K, Pipkorn U, Bake B, Blychert LO.
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [Abstract] [Full Text] [Related]

  • 20. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients.
    Gentile DA, Yokitis J, Angelini BL, Doyle WJ, Skoner DP.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):531-6. PubMed ID: 11379804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.